Indian Ritonavir Exporters: Complete Supplier Ranking with Market Share — 84 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ritonavir supplier from India?

HETERO LABS LIMITED is the largest ritonavir exporter from India with a 56.9% market share and export value of $193.8M.

Q: How many ritonavir suppliers are there in India?

There are 84 active ritonavir exporters in India, collectively shipping $340.6M worth of ritonavir across 1,555 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ritonavir suppliers from India?

The top 5 ritonavir suppliers from India — HETERO LABS LIMITED, MYLAN LABORATORIES LIMITED, CIPLA LIMITED, EMCURE PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LTD — together control 96.9% of total ritonavir export value from India.

Suresh Sormare

Ritonavir

India Pharmaceutical Trade Intelligence

$340.6M84 Suppliers155 CountriesHS 30049099

ExportsIndia → BELGIUM51.5%India → INDONESIA7.8%

ImportsUNITED STATES → India$92.3K BRAZIL → India$80.0K

#1 Supplier: HETERO LABS

Ritonavir Suppliers from India (2026) — 84 Exporters, $340.6M Market | TransData Nexus | TransData Nexus

Who Exports Ritonavir from India — 84 Suppliers Behind a $340.6M Market

India's ritonavir export market is supplied by 84 active exporters who collectively shipped $340.6M across 1,555 shipments. HETERO LABS LIMITED leads with a 56.9% market share, followed by MYLAN LABORATORIES LIMITED and CIPLA LIMITED. The top 5 suppliers together control 96.9% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Ritonavir Suppliers & Exporters — 84 manufacturers, $340.6M export market, top destinations and formulations — Ritonavir supplier data — 84 exporters · $340.6M market · 1,555 shipmentsTransData Nexus · Indian Customs Data

Top Ritonavir Exporters from India — Ranked by Export Value

HETERO LABS LIMITED is the leading ritonavir exporter from India, holding a 56.9% share of the $340.6M market across 1,555 shipments from 84 exporters. The top 5 suppliers — HETERO LABS LIMITED, MYLAN LABORATORIES LIMITED, CIPLA LIMITED, EMCURE PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LTD — collectively control 96.9% of total export value, indicating a highly concentrated market. Individual shares are: HETERO LABS LIMITED (56.9%), MYLAN LABORATORIES LIMITED (27.0%), CIPLA LIMITED (7.1%), EMCURE PHARMACEUTICALS LIMITED (4.5%), AUROBINDO PHARMA LTD (1.4%).

Top Ritonavir Exporters from India

Ranked by export value · 84 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Ritonavir Exporters from India — Ranked by Export Value. 84 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	HETERO LABS LIMITED

Ritonavir — Export Intelligence Video

Visual overview of India's ritonavir supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's ritonavir pharmaceutical supplier landscape — $340.6M in total trade, 84 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Ritonavir exporters

Certification and compliance status for top Ritonavir suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
HETERO LABS LIMITED	Approved	Yes	Yes	Multiple	Hetero Labs Ltd has received WHO prequalification for Dolutegravir (sodium) 50mg
MYLAN LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	Mylan Laboratories Ltd has received WHO prequalification for Efavirenz 50mg tabl
CIPLA LIMITED	Approved	Yes	Yes	Multiple	Cipla Ltd is listed among WHO GMP certified companies in India.
EMCURE PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	Emcure Pharmaceuticals Ltd has received WHO prequalification for Atazanavir (sul
AUROBINDO PHARMA LTD	Approved	Yes	Yes	Multiple	Aurobindo Pharma Ltd has received WHO prequalification for Dolutegravir (sodium)
MACLEODS PHARMACEUTICALS LTD	Approved	Yes	Yes	Multiple	Macleods Pharmaceuticals Ltd has received WHO prequalification for Artemether/Lu
MICRO LABS LIMITED	Approved	Yes	Yes	Multiple	Micro Labs Ltd is listed among WHO GMP certified companies in India.
AUROBINDO PHARMA LIMITED	Approved	Yes	Yes	Multiple	Aurobindo Pharma Ltd has received WHO prequalification for Dolutegravir (sodium)
MACLEODS PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	Macleods Pharmaceuticals Ltd has received WHO prequalification for Artemether/Lu

TransData Nexus reviewed the regulatory standing of 9 leading Ritonavir exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Ritonavir sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a central hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous pharmaceutical companies, including Aurobindo Pharma Limited, which is headquartered in Hyderabad. Aurobindo Pharma is a significant exporter of Ritonavir, contributing $4.9 million (1.4%) to the total exports. The city's well-established infrastructure and skilled workforce make it a critical node in the supply chain for APIs.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to several leading pharmaceutical companies, including Cipla Limited, which has a notable presence in the area. Cipla is a key exporter of Ritonavir, accounting for $24.1 million (7.1%) of the total exports. The cluster's emphasis on formulations complements the API production in other regions, ensuring a seamless supply chain from raw materials to finished products.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. This region's proximity to major ports facilitates efficient international distribution. Companies like Cipla Limited, headquartered in Mumbai, leverage this strategic location to export Ritonavir and other pharmaceuticals to global markets. The area's robust logistics infrastructure supports the high volume of pharmaceutical exports originating from this cluster.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Ritonavir exporters from India

December 2024

Regulatory Approval

Aurobindo Pharma Limited — Aurobindo Pharma receives FDA approval for Deutetrabenazine Tablets

On December 26, 2024, the U.S. Food and Drug Administration (FDA) approved Aurobindo Pharma's Abbreviated New Drug Application (ANDA) for Deutetrabenazine Tablets, indicated for the treatment of chorea associated with Huntington's disease. - IMPACT: This approval may enhance Aurobindo's market presence, potentially influencing its Ritonavir export capabilities.

Impact: This approval may enhance Aurobindo's market presence, potentially influencing its Ritonavir export capabilities.

December 2024

Regulatory Approval

Hetero Labs Limited — Hetero Labs secures FDA approval for Raltegravir Tablets

On December 19, 2024, the FDA approved Hetero Labs' ANDA for Raltegravir Tablets USP, used in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients. - IMPACT: This approval may bolster Hetero's antiretroviral portfolio, potentially affecting its Ritonavir export dynamics.

Impact: This approval may bolster Hetero's antiretroviral portfolio, potentially affecting its Ritonavir export dynamics.

Common Questions — Ritonavir Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which ritonavir supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, HETERO LABS LIMITED leads with 494 recorded shipments worth $193.8M. MYLAN LABORATORIES LIMITED (550 shipments) and CIPLA LIMITED (28 shipments) are also established high-volume exporters.

Q How many ritonavir manufacturers are there in India?

India has 84 active ritonavir exporters with a combined export market of $340.6M across 1,555 shipments to 155 countries. The top 5 suppliers hold 96.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for ritonavir from India?

Average FOB unit price: $20.57 per unit, ranging from $0.00 to $2500.00. Average shipment value: $219.0K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ritonavir

Ritonavir

Who Exports Ritonavir from India — 84 Suppliers Behind a $340.6M Market

Top Ritonavir Exporters from India — Ranked by Export Value

Top Ritonavir Exporters from India

Related Analysis

Need Details?

Ritonavir — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Aurobindo Pharma Limited — Aurobindo Pharma receives FDA approval for Deutetrabenazine Tablets

Hetero Labs Limited — Hetero Labs secures FDA approval for Raltegravir Tablets

Common Questions — Ritonavir Suppliers from India

Q Which ritonavir supplier from India is the most reliable for bulk orders?

Q How many ritonavir manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for ritonavir from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals files Draft Red Herring Prospectus for IPO

Analysis Methodology